ID
40154
Description
Study ID: 111582 Clinical Study ID: 111582 Study Title: An Open Label Study to Examine the Effects of Low-fat and High-fat Meals on the Pharmacokinetics of Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer Patients. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00821054 https://clinicaltrials.gov/ct2/show/NCT00821054 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: Lapatinib Trade Name: N/A Study Indication: Neoplasms, Breast The study consists of a screening, four study visits at day-1, week 1, 2 and 3 and a follow-up visit. This document contains the medical conditions of the patient. It has to be filled in for screening.
Link
https://clinicaltrials.gov/ct2/show/NCT00821054
Keywords
Versions (2)
- 3/16/20 3/16/20 - Christian Arras
- 3/17/20 3/17/20 - Sarah Riepenhausen
Copyright Holder
GlaxoSmithKline
Uploaded on
March 17, 2020
DOI
To request one please log in.
License
Creative Commons BY-NC 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Effects of Low-fat and high-fat meals on the Pharmacokinetics of Lapatinib in ErB2+ Breast Cancer patients, NCT00821054
Similar models
Medical conditions
- StudyEvent: ODM
C2348235 (UMLS CUI [1,2])
C0805701 (UMLS CUI [1,2])
C0012634 (UMLS CUI [1,3])